Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants

Authors Information
Article Notes and Dates
To Cite : De Waele K, Cools M, De Guchtenaere A, Van de Walle J, Raes A, et al. Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants, Int J Endocrinol Metab. 2014 ;12(4):e16120. doi: 10.5812/ijem.16120.
Copyright: Copyright © 2014, International Journal of Endocrinology and Metabolism. .
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Majzoub JA, Srivatsa A. Diabetes insipidus: clinical and basic aspects. Pediatr Endocrinol Rev. 2006; 4 Suppl 1: 60-5[PubMed]
  • 2. Baruteau J, Cartault A, Chanot A, Sevely A, Casper C. Neonatal Escherichia coli meningitis can be complicated by central permanent diabetes insipidus. J Pediatr Endocrinol Metab. 2009; 22(3): 213[PubMed]
  • 3. Mohn A, Schoof E, Fahlbusch R, Wenzel D, Dorr HG. The endocrine spectrum of arachnoid cysts in childhood. Pediatr Neurosurg. 1999; 31(6): 316-21[PubMed]
  • 4. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, et al. Central diabetes insipidus in children and young adults. N Engl J Med. 2000; 343(14): 998-1007[DOI][PubMed]
  • 5. Rivkees SA, Dunbar N, Wilson TA. The management of central diabetes insipidus in infancy: desmopressin, low renal solute load formula, thiazide diuretics. J Pediatr Endocrinol Metab. 2007; 20(4): 459-69[PubMed]
  • 6. Andersson KE, Arner B. Effects of DDAVP, a synthetic analogue of vasopressin, in patients with cranial diabetes insipidus. Acta Med Scand. 1972; 192(1-2): 21-7[PubMed]
  • 7. Vande Walle J, Stockner M, Raes A, Norgaard JP. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf. 2007; 2(3): 232-8[PubMed]
  • 8. Fjellestad-Paulsen A, Paulsen O, d'Agay-Abensour L, Lundin S, Czernichow P. Central diabetes insipidus: oral treatment with dDAVP. Regul Pept. 1993; 45(1-2): 303-7[PubMed]
  • 9. Blanco EJ, Lane AH, Aijaz N, Blumberg D, Wilson TA. Use of subcutaneous DDAVP in infants with central diabetes insipidus. J Pediatr Endocrinol Metab. 2006; 19(7): 919-25[PubMed]
  • 10. Thumfart J, Roehr CC, Kapelari K, Querfeld U, Eggert P, Muller D. Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors? J Urol. 2005; 174(1): 294-8[DOI][PubMed]
  • 11. Steiner IM, Kaehler ST, Sauermann R, Rinosl H, Muller M, Joukhadar C. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers. Int J Clin Pharmacol Ther. 2006; 44(4): 172-9[PubMed]
  • 12. Vande Walle JG, Bogaert GA, Mattsson S, Schurmans T, Hoebeke P, Deboe V, et al. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int. 2006; 97(3): 603-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check